Christophe Erneux

Dr. Christophe Erneux

Université Libre de Bruxelles, Brussels, Brussels-Capital Region, Belgium
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1998 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
CEChristophe Erneux
Christophe Erneux
CGCédric Govaerts
Cédric Govaerts
DCDavid Communi
David Communi
XPXavier Pesesse
Xavier Pesesse

15 March 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
WEWilliam'S Elong Edimo
William'S Elong Edimo
SGSomadri Ghosh
Somadri Ghosh
RDRita Derua
Rita Derua
VJVeerle Janssens
Veerle Janssens
EWEtienne Waelkens
Etienne Waelkens
CEChristophe Erneux
Christophe Erneux
Phosphoinositides, particularly phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], are recognized by SHIP2 (also known as INPPL1) a member of the inositol polyphosphate 5-phosphatase family. SHIP2 dephosphorylates PI(3,4,5)P3 to form PI(3,4)P2; the latter interacts with specific target proteins (e.g. lamellipodin). Although the preferred SHIP2 substrate is PI(3,4,5)P3, PI(4,5)P2 can also be dephosphorylated by this enzyme to phosphatidylinositol 4-phosphate (PI4P). Through depletion of SHIP2 in the glioblastoma cell line 1321 N1, we show that SHIP2 inhibits cell migration. In different glioblastoma cell lines and primary cultures, SHIP2 staining at the plasma membrane partly overlaps with PI(4,5)P2 immunoreactivity. PI(4,5)P2 was upregulated in SHIP2-deficient N1 cells as compared to control cells; in contrast, PI4P was very much decreased in SHIP2-deficient cells. Therefore, SHIP2 controls both PI(3,4,5)P3 and PI(4,5)P2 levels in intact cells. In 1321 N1 cells, the PI(4,5)P2-binding protein myosin-1c was identified as a new interactor of SHIP2. Regulation of PI(4,5)P2 and PI4P content by SHIP2 controls 1321 N1 cell migration through the organization of focal adhesions. Thus, our results reveal a new role of SHIP2 in the control of PI(4,5)P2, PI4P and cell migration in PTEN-deficient glioblastoma 1321 N1 cells.

29 June 2007 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
DBDaniel Blero
Daniel Blero
BPBernard Payrastre
Bernard Payrastre
SSStéphane Schurmans
Stéphane Schurmans
CEChristophe Erneux
Christophe Erneux

30 January 2007 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
FVFabrice Vandeput
Fabrice Vandeput
Laurent COMBETTESLaurent COMBETTES
Laurent COMBETTES
SMStephen J. Mills
Stephen J. Mills
KBKatrien Backers
Katrien Backers
AWAlexandre Wohlkönig
Alexandre Wohlkönig
CEChristophe Erneux
Christophe Erneux
Benzene polyphosphates containing phosphate groups on one ring are Ins(1,4,5)P 3 5‐phosphatase inhibitors when evaluated against type‐I Ins(1,4,5)P 3 5‐phosphatase. A novel biphenyl derivative, biphenyl 2,3′,4,5′,6‐pentakisphosphate, with five phosphate groups on two rings was synthesized: It inhibited the activity of two inositol 5‐phosphatases: type I and SHIP2 with Ins(1,3,4,5)P 4 as substrate. The inhibition was competitive with respect to the substrate. IC 50 value measured in rat hepatocytes, which contains the native Ins(1,4,5)P 3 5‐phosphatase, was in the micromolar range at 1.0 μM Ins(1,4,5)P 3 as substrate. Biphenyl 2,3′,4,5′,6‐pentakisphosphate did not affect the activity of Ins(1,4,5)P 3 3‐kinase A in the 5‐100 μM range. Surprisingly, experimental evidence supports an effect of biphenyl 2,3′,4,5′,6‐pentakisphosphate at the level of the Ins(1,4,5)P 3 receptor. Finally, when injected into rat hepatocytes, the analog affected the frequency of Ca 2+ oscillations in a positive or negative way depending on its concentration. At very high concentrations of the analog, Ca 2+ oscillations were even suppressed. These data were interpreted as a dual effect of the biphenyl 2,3′,4,5′,6‐pentakisphosphate on cytosolic [Ca 2+ ] increases: an activation effect through an increase in Ins(1,4,5)P 3 level via Ins(1,4,5)P 3 5‐phosphatase inhibition and an inhibitory effect, which was exerted directly on the Ins(1,4,5)P 3 receptor. Thus, our data show for the first time that the frequency of Ca 2+ oscillations in response to a Ca 2+ ‐mobilizing agonist can be controlled by inhibitors of type‐I Ins(1,4,5)P 3 5‐phosphatase.—Vandeput, F., Combettes, L., Mills, S. J., Backers, K., Wohlkönig, A., Parys, J. B., De Smedt, H., Missiaen, L., Dupont, G., Potter, B. V. L., Erneux, C. Biphenyl 2,3′,4,5′,6‐pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca2+ responses in rat hepatocytes. FASEB J. 21, 1481–1491 (2007)

1 July 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FSFlorence De Smedt
Florence De Smedt
LMLudwig Missiaen
Ludwig Missiaen
Jan ParysJan Parys
Jan Parys
VVValérie Vanweyenberg
Valérie Vanweyenberg
HSHumbert De Smedt
Humbert De Smedt
CEChristophe Erneux
Christophe Erneux
D-myo-Inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase and 3-kinase are thought to be critical regulatory enzymes in the control of InsP3 and Ca2+ signaling. In brain and many other cells, type I InsP3 5-phosphatase is the major phosphatase that dephosphorylates InsP3 andd-myo-inositol 1,3,4,5-tetrakisphosphate. The type I 5-phosphatase appears to be associated with the particulate fraction of cell homogenates. Molecular cloning of the human brain enzyme identifies a C-terminal farnesylation site CVVQ. Post-translational modification of this enzyme promotes membrane interactions and changes in specific activity. We have now compared the cytosolic Ca2+ ([Ca2+]i) responses induced by ATP, thapsigargin, and ionomycin in Chinese hamster ovary (CHO-K1) cells transfected with the intact InsP35-phosphatase and with a mutant in which the C-terminal cysteine cannot be farnesylated. [Ca2+]i was also measured in cells transfected with an InsP3 3-kinase construct encoding the A isoform. The Ca2+ oscillations detected in the presence of 1 μm ATP in control cells were totally lost in 87.5% of intact (farnesylated) InsP35-phosphatase-transfected cells, while such a loss occurred in only 1.1% of the mutant InsP3 5-phosphatase-transfected cells. All cells overexpressing the InsP3 3-kinase also responded with an oscillatory pattern. However, in contrast to control cells, the [Ca2+]i returned to base-line levels in between a couple of oscillations. The [Ca2+]i responses to thapsigargin and ionomycin were identical for all cells. The four cell clones compared in this study also behaved similarly with respect to capacitative Ca2+ entry. In permeabilized cells, no differences in extent of InsP3-induced Ca2+release nor in the threshold for InsP3 action were observed among the four clones and no differences in the expression levels of the various InsP3 receptor isoforms could be shown between the clones. Our data support the contention that the ATP-induced increase in InsP3 concentration in transfected CHO-K1 cells is essentially restricted to the site of its production near the plasma membrane, where it can be metabolized by the type I InsP35-phosphatase. This enzyme directly controls the [Ca2+]i response and the Ca2+oscillations in intact cells.

18 August 2011 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CEChristophe Erneux
Christophe Erneux
WEWilliam'S Elong Edimo
William'S Elong Edimo
LDLaurence Deneubourg
Laurence Deneubourg
IPIsabelle Pirson
Isabelle Pirson